Focal Segmental Glomerulosclerosis
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele–associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy ( e.g ., glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence ( e.g ., to rule out other primary glomerulopathies), and electron microscopy ( e.g. , extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Focal segmental glomerulosclerosis (FSGS) is a fibrotic kidney disease characterized by glomerular lesions, particularly in podocytes — the formation of adhesions in the glomerular capillary tuft leads to capillary occlusion and nephron degeneration162.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [162]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
BackgroundSelf-citationMann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationCirculating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Cited by
Items 101–200 of 642
Bai, J., Zhang, T., Wang, Y., Cao, J., Duan, Z., Ji, L., Zhou, Y., Hao, C., & Guo, Q. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2201341 · Cited by 25
Mechanisms of Scarring in Focal Segmental Glomerulosclerosis
Sun, K., Xie, Q., & Hao, C. (2021) · Kidney Diseases · doi:10.1159/000517108 · Cited by 25
Cui, X., Fu, J., Luan, J., Qi, H., Jiao, C., Ran, M., Wang, D., Hao, X., Zhang, Y., Kopp, J. B., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.066 · Cited by 24
Self-citationEmerging Roles of Circ-ZNF609 in Multiple Human Diseases
Wang, S., Wu, J., Wang, Z., Gong, Z., Liu, Y., & Wang, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.837343 · Cited by 24
Ters, M. E., Vairo, F. P. E., Prochnow, C. A., Schinstock, C. A., Dean, P. G., Kemppainen, J. L., Lazaridis, K., Cosio, F., Fervenza, F. C., Cornell, L. D., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004363 · Cited by 24
Trachtman, H., Komers, R., & Inrig, J. K. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2319132 · Cited by 24
Gao, Y., Bi, L., Li, A., Du, M., Song, M., & Jiang, G. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c00792 · Cited by 24
Epigenetics of Hypertensive Nephropathy
Zhang, Y., Arzaghi, H., Ma, Z., Roye, Y., & Musah, S. (2024) · Biomedicines · doi:10.3390/biomedicines12112622 · Cited by 24
Toll-Like Receptor as a Potential Biomarker in Renal Diseases
Mertowski, S., Lipa, P., Morawska, I., Niedźwiedzka‐Rystwej, P., Bębnowska, D., Hrynkiewicz, R., Grywalska, E., Roliński, J., & Załuska, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186712 · Cited by 24
Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting
Tsuboi, N., Sasaki, T., Okabayashi, Y., Haruhara, K., Kanzaki, G., & Yokoo, T. (2021) · Hypertension Research · doi:10.1038/s41440-020-00612-y · Cited by 24
Siligato, R., Cernaro, V., Nardi, C., Gregorio, F. D., Gembillo, G., Costantino, G., Conti, G., Buemi, M., & Santoro, D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1540587 · Cited by 24
Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety
Zhang, B., & Deng, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1574693 · Cited by 24
PodoCount: A Robust, Fully Automated, Whole-Slide Podocyte Quantification Tool
Santo, B. A., Govind, D., Daneshpajouhnejad, P., Yang, X., Wang, X. X., Myakala, K., Jones, B. A., Levi, M., Kopp, J. B., Yoshida, T., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.03.004 · Cited by 23
Self-citationThe spatially resolved transcriptome signatures of glomeruli in chronic kidney disease
Clair, G., Soloyan, H., Cravedi, P., Angeletti, A., Salem, F. E., Al-Rabadi, L. F., Filippo, R. E. D., Sacco, S. D., Lemley, K. V., Sedrakyan, S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.165515 · Cited by 23
The Role of MicroRNAs in Selected Forms of Glomerulonephritis
Nalewajska, M., Gurazda, K., Styczyńska-Kowalska, E., Marchelek‐Myśliwiec, M., Pawlik, A., & Dziedziejko, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205050 · Cited by 23
Li, F., Fang, Y., Zhuang, Q., Cheng, M., Moronge, D., Jue, H., Meyuhas, O., Ding, X., Zhang, Z., Chen, J., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.02.037 · Cited by 22
The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis
Jia, T., Xu, T., Smeets, B., Buhl, E. M., Moeller, M. J., Floege, J., Klinkhammer, B. M., & Boor, P. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022040491 · Cited by 22
Cambier, A., Patey, N., Royal, V., Gougeon, F., Genest, D. S., Brachemi, S., Bollée, G., Merlen, C., Bonnefoy, A., Lapeyraque, A., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.12.015 · Cited by 22
Campbell, K. N., Gesualdo, L., Murphy, E., Rheault, M. N., Srivastava, T., Tesař, V., Komers, R., & Trachtman, H. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100833 · Cited by 22
Anígilájé, E. A., & Olutola, A. (2019) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s193874 · Cited by 22
Jacobs-Cachá, C., Puig-Gay, N., Helm, D., Rettel, M., Sellarès, J., Meseguer, A., Savitski, M. M., Moreso, F., Soler, M. J., Serón, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58197-y · Cited by 22
Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis
Tanoue, A., Katayama, K., Ito, Y., Joh, K., Toda, M., Yasuma, T., D’Alessandro‐Gabazza, C. N., Kawachi, H., Yan, K., Ito, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00159-z · Cited by 22
Karanović, D., Mihailovic‐Stanojevic, N., Miloradović, Z., Ivanov, M., Vajić, U.-J., Grujić-Milanović, J. D., Markovic‐Lipkovski, J., Dekanski, D., & Jovović, D. (2020) · Phytotherapy Research · doi:10.1002/ptr.6920 · Cited by 21
Saga, N., Sakamoto, K., Matsusaka, T., & Nagata, M. (2021) · Kidney International · doi:10.1016/j.kint.2020.12.034 · Cited by 21
Trachtman, H., Kretzler, M., Gesualdo, L., Cross, N., Workeneh, B., Kaufeld, J. K., Meijers, B. K. I., Ye, Z., Chen, Q., Derebail, V. K., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02255-x · Cited by 20
Xu, C., Liu, X., Zhai, X., Wang, G., Qin, W., Cheng, Z., & Chen, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115617 · Cited by 20
INF2 mutations cause kidney disease through a gain-of-function mechanism
Subramanian, B., Williams, S., Karp, S., Hennino, M.-F., Jacas, S., Lee, M., Riella, C. V., Alper, S. L., Higgs, H. N., & Pollak, M. R. (2024) · Science Advances · doi:10.1126/sciadv.adr1017 · Cited by 20
miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis
Qi, H., Fu, J., Luan, J., Jiao, C., Cui, X., Cao, X., Zhang, Y., Wang, Y., Kopp, J. B., Pi, J., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.096 · Cited by 20
Self-citationSolanki, A. K., Srivastava, P. K., Rahman, B., Lipschutz, J. H., Nihalani, D., & Arif, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010274 · Cited by 20
Ito, N., Sakamoto, K., Hikichi, C., Matsusaka, T., & Nagata, M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00414.2019 · Cited by 20
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases
Hummel, A., Oniszczuk, J., Kervella, D., Charbit, M., Guerrot, D., Testa, A., Philipponnet, C., Chauvet, C., Guincestre, T., Brochard, K., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac134 · Cited by 20
Focal Segmental Glomerulosclerosis
Kopp, J. B., Rosenberg, A. Z., & Schnaper, H. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47794-9.00018-4 · Cited by 20
Self-citationDexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats
Hu, H., Xie, C., Weng, Z., Yu, P., Wang, Y., & Shan, L. (2022) · Pharmacology · doi:10.1159/000521220 · Cited by 19
Modeling of ACTN4-Based Podocytopathy Using Drosophila Nephrocytes
Odenthal, J., Dittrich, S., Ludwig, V., Merz, T., Reitmeier, K., Reusch, B., Höhne, M., Cosgun, Z. C., Hohenadel, M. G., Putnik, J., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.024 · Cited by 19
Qiao, Y., Wang, P., Chang, M., Chen, B., Ge, Y., Malhotra, D. K., Dworkin, L. D., & Gong, R. (2020) · Clinical Science · doi:10.1042/cs20200016 · Cited by 19
Role of TGF-β signalling in PCOS associated focal segmental glomerulosclerosis
Bhati, M., Prabhu, Y. D., Renu, K., Vellingiri, B., Thiagarajan, P., Panda, A., Chakraborty, R., Myakala, H., & Gopalakrishnan, A. V. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.032 · Cited by 19
suPAR, a Circulating Kidney Disease Factor
Wei, C., Spear, R., Hahm, E., & Reiser, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745838 · Cited by 19
Potter, A. S., Drake, K. A., Brunskill, E. W., & Potter, S. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216261 · Cited by 19
Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases
Pablo, J. L., & Greka, A. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.001 · Cited by 18
Widiasta, A., Wahyudi, K., Sribudiani, Y., & Rachmadi, D. (2021) · Biomedicine · doi:10.37796/2211-8039.1205 · Cited by 18
Targeting Glomerular Hemodynamics for Kidney Protection
Savedchuk, S., Phachu, D., Shankar, M., Sparks, M. A., & Harrison‐Bernard, L. M. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2022.12.003 · Cited by 18
Schindler, M., Siegerist, F., Lange, T., Simm, S., Bach, S.-M., Klawitter, M., Gehrig, J., Gul, S., & Endlich, N. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000235 · Cited by 18
Chen, R., Zhang, L., Ye, W., Wen, Y.-B., Si, N., Li, H., Li, M., Li, X., & Zheng, K. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0913-6 · Cited by 18
Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS
Bukosza, É. N., Kratochwill, K., Kornauth, C., Schachner, H., Aufricht, C., & Gebeshuber, C. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231898 · Cited by 18
Dou, C., Zhang, H., Ke, G., Zhang, L., Lian, Z., Chen, X., Zhao, X., Chen, Y., Li, R., Ma, J., et al. (2020) · Clinical Science · doi:10.1042/cs20200075 · Cited by 18
Collard, D., van Brussel, P. M., van de Velde, L., Wijntjens, G. W. M., Westerhof, B. E., Karemaker, J. M., Piek, J. J., Reekers, J. A., Vogt, L., de Winter, R. J., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019121272 · Cited by 18
Differentiating primary and secondary FSGS using non-invasive urine biomarkers
Catanese, L., Siwy, J., Wendt, R. T., Amann, K., Beige, J., Hendry, B. M., Mischak, H., Mullen, W., Paterson, I., Schiffer, M., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad296 · Cited by 17
Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics
Bărar, A. A., Pralea, I.-E., Maslyennikov, Y., Munteanu, R. A., Berindan‐Neagoe, I., Pîrlog, R., Rusu, I., Nutu, A. M., Rusu, C. C., Moldovan, D. T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115613 · Cited by 17
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes
Issa, W., Njeim, R., Carrazco, A., Burke, G. W., & Mitrofanova, A. V. (2024) · Cells · doi:10.3390/cells13131157 · Cited by 17
Schaub, J. A., O'Connor, C. L., Shi, J., Wiggins, R. C., Shedden, K., Hodgin, J. B., & Bitzer, M. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207149 · Cited by 17
PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis
Beck, L. H., Berasi, S. P., Copley, J. B., Gorman, D. N., Lévy, D., Lim, C. N., Henderson, J., Salant, D. J., & Lu, W. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.03.892 · Cited by 17
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
Liu, F., Chen, J., Luo, C., & Meng, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.948094 · Cited by 17
Pekkucuksen, N. T., Liu, L., Aly, R., Shoemaker, L. R., & Alli, A. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274598 · Cited by 17
Elimam, H., Papillon, J., Guillemette, J., Navarro‐Betancourt, J. R., & Cybulsky, A. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-52834-x · Cited by 17
Ma, H.-Y., Lai, C.-C., Chiu, N., & Lee, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.008 · Cited by 17
Vizcarra, C. A. V., Chávez-Velázquez, E., Asato-Higa, C., & Hurtado-Aréstegui, A. (2022) · High Altitude Medicine & Biology · doi:10.1089/ham.2021.0158 · Cited by 16
Qing, X., Jiang, J., Yuan, C., Xie, K., & Wang, K. (2024) · Journal of Nephrology · doi:10.1007/s40620-024-01914-x · Cited by 16
Roles of microRNAs in renal disorders related to primary podocyte dysfunction
Iranzad, R., Motavalli, R., Ghassabi, A., Pourakbari, R., Etemadi, J., & Yousefi, M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119463 · Cited by 16
Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation
Shamsi, H. A., Shaheen, I. S., & Aziz, D. (2021) · Transplantation Reviews · doi:10.1016/j.trre.2021.100675 · Cited by 16
Qiu, Y., Lei, C., Zeng, J., Xie, Y., Cao, Y., Qian, Y., Su, H., Zhang, Z., & Zhang, C. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.09.003 · Cited by 16
Chao, Y.-C., Trachtman, H., Gipson, D. S., Spino, C., Braun, T., & Kidwell, K. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.105989 · Cited by 16
Wang, X., Xiang, J., Huang, G., Kang, L., Yang, G., Wu, H., Jiang, K., Liang, Z., & Yang, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.779652 · Cited by 16
Recent findings on the role of microRNAs in genetic kidney diseases
Askari, H., Raeis-Abdollahi, E., Abazari, M. F., Akrami, H., Vakili, S., Savardashtaki, A., Tajbakhsh, A., Sanadgol, N., Azarnezhad, A., Rahmati, L., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07620-w · Cited by 16
Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases
Alkaff, F. F., Lammerts, R. G. M., Daha, M. R., Berger, S. P., & van den Born, J. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae215 · Cited by 15
Munis, M. A., Chen, Q., Hill, M., Zhuo, M., Schachter, A. D., Bhandari, S. K., Hever, A., Harrison, T. N., Fernandes, A. W., & Sim, J. J. (2024) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000590 · Cited by 16
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis
Mariani, L., Trachtman, H., Thompson, A., Gillespie, B. S., Denburg, M., Diva, U., Geetha, D., Greasley, P. J., Hladunewich, M., Huizinga, R. B., et al. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.08.011 · Cited by 15
Rare inherited kidney diseases: an evolving field in Nephrology
da Cunha, M. F. M., Sevignani, G., Pavanelli, G. M., Carvalho, M., & Barreto, F. C. (2020) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0217 · Cited by 15
Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach
Zanoni, F., Khairallah, P., Kiryluk, K., & Batal, I. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.01.005 · Cited by 15
Léon, J., Pérez‐Sáez, M. J., Uffing, A., Murakami, N., Watanabe, A., Cureton, P., Kenyon, V., Keating, L., Yee, K., Satiro, C. A. F., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.02.011 · Cited by 15
Srivastava, P. K., Solanki, A. K., Arif, E., Wolf, B. J., Janech, M. G., Budisavljevic, M. N., Kwon, S., & Nihalani, D. (2019) · Kidney International · doi:10.1016/j.kint.2018.10.030 · Cited by 15
Bouts, A. H. M., Veltkamp, F., Tönshoff, B., Vivarelli, M., & Members of the Working Group “Transplantation”, “. N. S. O. T. E. S. O. P. N. (2019) · Pediatric Transplantation · doi:10.1111/petr.13385 · Cited by 15
Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis
Verzola, D., Saio, M., Picciotto, D., Viazzi, F. C., Russo, E., Cipriani, L., Carta, A., Costigliolo, F., Gaggero, G., Salvidio, G., et al. (2020) · American Journal of Nephrology · doi:10.1159/000511560 · Cited by 15
The IRE1α pathway in glomerular diseases: The unfolded protein response and beyond
Navarro‐Betancourt, J. R., & Cybulsky, A. V. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.971247 · Cited by 14
Liu, G., He, L., Yang, X., Tang, L., Shi, W., She, J., & Wei, J. (2022) · The Nephron journals/Nephron journals · doi:10.1159/000525233 · Cited by 14
Mutation Analysis of Thin Basement Membrane Nephropathy
Hirabayashi, Y., Katayama, K., Mori, M., Matsuo, H., Fujimoto, M., Joh, K., Murata, T., Ito, M., & Dohi, K. (2022) · Genes · doi:10.3390/genes13101779 · Cited by 14
Heybeli, C., Oktan, M. A., Yıldız, S., Ünlü, M., Çelik, A., & Sarıoğlu, S. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-01688-0 · Cited by 14
Zhang, G., & Li, Q. (2019) · Medical Science Monitor · doi:10.12659/msm.917312 · Cited by 14
Harita, Y. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1449-y · Cited by 14
Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage
Braun, F., Mandel, A. M., Blomberg, L., Wong, M. N., Chatzinikolaou, G., Meyer, D. H., Reinelt, A., Nair, V., Akbar-Haase, R., McCown, P. J., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.172370 · Cited by 13
Potential contribution of the immune system to the emergence of renal diseases
Ghassabi, A., Motavalli, R., Iranzad, R., Pourakbari, R., Etemadi, J., Dolati, S., & Yousefi, M. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.06.003 · Cited by 13
Possemiers, H., Pollenus, E., Prenen, F., Knoops, S., Koshy, P. J., & den Steen, P. E. V. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.915792 · Cited by 13
Trachtman, H., Diva, U., Murphy, E., Wang, K., Inrig, J. K., & Komers, R. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.07.022 · Cited by 13
Puapatanakul, P., Isaranuwatchai, S., Chanakul, A., Surintrspanont, J., Iampenkhae, K., Kanjanabuch, T., Suphapeetiporn, K., Charu, V., Suleiman, H. Y., Praditpornsilpa, K., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.01.036 · Cited by 13
Shuai, T., Jing, Y., Huang, Q., Xiong, H., Liu, J., Zhu, L., Yang, K., & Liu, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031812 · Cited by 13
Hou, Y., Diao, T.-T., Xu, Z., Mao, X.-Y., Wang, C., & Li, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.691966 · Cited by 13
Liao, M.-C., Miyata, K. N., Chang, S.-Y., Zhao, X.-P., Lo, C., El-Mortada, M.-A., Peng, J., Chénier, I., Yamashita, M., Ingelfinger, J. R., et al. (2022) · Clinical Science · doi:10.1042/cs20220188 · Cited by 13
Mesoamerican nephropathy: pathology in search of etiology
Haas, M. (2018) · Kidney International · doi:10.1016/j.kint.2017.09.025 · Cited by 13
Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice
Woychyshyn, B., Papillon, J., Guillemette, J., Navarro‐Betancourt, J. R., & Cybulsky, A. V. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00028.2020 · Cited by 13
Watanabe, M., Takahashi, Y., Hiura, K., Nakano, K., Okamura, T., Sasaki, H., & Sasaki, N. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.150 · Cited by 13
Patterns of Glomerular Injury: Histopathological Classification and Clinical Correlation
Qasim, H., Shugaer, M. A., Dibian, S., Ktaifan, M., Khattab, K., Leoni, M. L. G., & Varrassi, G. (2025) · Cureus · doi:10.7759/cureus.91728 · Cited by 12
c-Src is in the effector pathway linking uPAR and podocyte injury
Kopp, J. B., & Heymann, J. A. W. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127927 · Cited by 12
Self-citationGiudicelli, G. C., de Souza, C. M. B., Veronese, F. V., Pereira, L. V., Hünemeier, T., & Vianna, F. S. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1016341 · Cited by 12
Kwon, H. E., Kim, Y. H., Lee, S. A., Lee, J. J., Ko, Y., Shin, S. H., Jung, J. H., Sung, F. S., Baek, C. H., Kim, H., et al. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03098-1 · Cited by 12
Gonçalves, G. L., Costa-Pessoa, J. M., Pimenta, R., da Silva, A. F. T., da Silva, E. M., Ledesma, F. L., Malheiros, D. M. A. C., Zatz, R., Thieme, K., Câmara, N. O. S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-49861-0 · Cited by 12
da Silva, C. A., Araújo, L. S., Monteiro, M. L. G. D. R., Pereira, L. H. D. M., da Silva, M. V., Castellano, L. R. C., Corrêa, R. R. M., dos Reis, M. A., & Machado, J. R. (2019) · Disease Markers · doi:10.1155/2019/1070495 · Cited by 12
Liu, G., Wang, Q., Shi, Y., Peng, X., Liu, H., Peng, Y., & He, L. (2017) · Pharmacology · doi:10.1159/000479525 · Cited by 12
Lu, M., Wang, P., Ge, Y., Dworkin, L. D., Brem, A. S., Liu, Z., & Gong, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-29483-7 · Cited by 12
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
Gipson, D. S., Hladunewich, M., Lafayette, R. A., Sedor, J. R., Rovin, B. H., Barbour, S. J., McMahon, A. W., Jennette, J. C., Nachman, P. H., Willette, R. N., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.05.024 · Cited by 12
Bensink, M. E., Goldschmidt, D., Zhou, Z., Wang, K., Lieblich, R., & Bunke, C. M. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100760 · Cited by 11
May, C., Ford, N. P., Welsh, G. I., & Saleem, M. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312232 · Cited by 11
Metadata
- Authors
- Rosenberg, A. Z., & Kopp, J. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Rosenberg, Avi Z.
- Kopp, Jeffrey B.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 3
- Pages
- 502-517
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5338705
- OpenAlex
- W2593771998
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 43 · 2025: 71 · 2024: 86 · 2023: 79 · 2022: 79 · 2021: 62 · 2020: 65 · 2019: 46 · 2018: 22 · 2017: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- focal segmental glomerulosclerosis, APOL1 risk alleles, renal biopsy, podocyte ultrastructure, genetic testing
- MeSH terms
- Apolipoprotein L1, Angiotensin-Converting Enzyme Inhibitors, Drug Therapy, Combination, Glomerulosclerosis, Focal Segmental, Glucocorticoids, Humans, Immunosuppressive Agents, HIV Infections, Angiotensin Receptor Antagonists, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.